QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 3,900.00
-300.00 (-7.14%)
At close: Nov 6, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 44.78 billion as of November 5, 2026. It is the 32,259th most valuable company in the world and the 1,790th biggest in South Korea.
Market Cap
44.78B
Enterprise Value
35.52B
Revenue
7.14B
Global Rank
Country Rank
#1,790 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 44.78B, a decrease of -77.60%. That is a compound annual growth rate of -80.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 44.78B | -74.67% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 57.82B |
| PanGen Biotech | 55.41B |
| TegoScience | 53.72B |
| KoBioLabs | 51.46B |
| Psomagen | 51.36B |
| NovMetaPharma | 50.72B |
| Epibiotech | 48.21B |
| ADBiotech | 45.82B |